Israel - hebreo - Ministry of Health

naomi shaco-ezra ltd - buprenorphine as hydrochloride; naloxone as hydrochloride dihydrate - buprenorphine as hydrochloride 2 mg; naloxone as hydrochloride dihydrate 0.5 mg - buprenorphine

Israel - hebreo - Ministry of Health

naomi shaco-ezra ltd - buprenorphine as hydrochloride; naloxone as hydrochloride dihydrate - buprenorphine as hydrochloride 8 mg; naloxone as hydrochloride dihydrate 2 mg - buprenorphine

Israel - hebreo - Ministry of Health

kamada ltd, israel - beclometasone dipropionate; formoterol fumarate dihydrate; glycopyrronium as bromide - glycopyrronium as bromide 9 mcg/delivered dose; formoterol fumarate dihydrate 5.2 mcg/delivered dose; beclometasone dipropionate 87.4 mcg/delivered dose - formoterol, glycopyrronium bromide and beclometasone

Israel - hebreo - Ministry of Health

kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - formoterol fumarate dihydrate 6 mcg/actuation; beclometasone dipropionate anhydrous 200 mcg/actuation - formoterol and beclometasone

Israel - hebreo - Ministry of Health

astrazeneca (israel) ltd - budesonide; formoterol fumarate dihydrate; glycopyrronium - תרחיף לשאיפה - formoterol fumarate dihydrate 5 mcg; glycopyrronium 7.2 mcg; budesonide 160 mcg - budesonide

Israel - hebreo - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose anhydrous as monohydrate; lactic acid; magnesium chloride hexahydrate; potassium chloride; sodium chloride; sodium hydrogen carbonate - תמיסה להמודיאליזה\המופילטרציה - calcium chloride dihydrate 5.145 g/l; magnesium chloride hexahydrate 2.033 g/l; glucose anhydrous as monohydrate 22.00 g/l; lactic acid 5.400 g/l; sodium chloride 6.45 g/l; sodium hydrogen carbonate 3.090 g/l; potassium chloride 0.157 g/l - combinations

Israel - hebreo - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose anhydrous; lactic acid; magnesium chloride hexahydrate; potassium chloride; sodium chloride; sodium hydrogen carbonate - תמיסה להמודיאליזה\המופילטרציה - calcium chloride dihydrate 5.145 g/l; magnesium chloride hexahydrate 2.033 g/l; glucose anhydrous 22.00 g/l; lactic acid 5.400 g/l; sodium chloride 6.45 g/l; sodium hydrogen carbonate 3.090 g/l; potassium chloride 0.314 g/l - combinations

Israel - hebreo - Ministry of Health

novartis israel ltd - ondansetron as hydrochloride dihydrate - תמיסה להזרקה - ondansetron as hydrochloride dihydrate 2 mg/ml - ondansetron - ondansetron - adults:zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (ponv). paediatric population:zofran is indicated for the management of chemotherapy-induced nausea and vomiting (cinv) in children aged ?6 months, and for the prevention and treatment of ponv in children aged ?2 years.

Israel - hebreo - Ministry of Health

neopharm (israel) 1996 ltd - ondansetron as hydrochloride dihydrate - תמיסה להזרקה - ondansetron as hydrochloride dihydrate 2 mg/ml - ondansetron - ondansetron - adults:for the mangement of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy.for the prevention and treatment of post-operative nausea and vomiting (ponv).paediatric population:for the mangement of chemotherapy-induced nausea and vomiting (cinv) in children aged ? 6 months, and for the prevention and treatment of ponv in children aged ? 2 years.

Israel - hebreo - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - ondansetron as hydrochloride dihydrate - תמיסה להזרקה - ondansetron as hydrochloride dihydrate 2 mg/ml - ondansetron - ondansetron - adults: odnatron is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. odnatron is indicated for the prevention and treatment of post-operative nausea and vomiting (ponv).paediatric population: odantron is indicated for the management of chemotherapy-induced nausea and vomiting (cinv) in children aged ?6 months, and for the prevention and treatment of ponv in children aged ?2 years.